ArticleTheranostics2026

Visualizing the distribution of durvalumab targeting PD-L1 using quantitative fluorescence imaging in patients with esophageal cancer.

Anne M van der Waaij et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.